119 related articles for article (PubMed ID: 10371356)
1. Allelic loss on chromosome 6Q in primary prostate cancer.
Srikantan V; Sesterhenn IA; Davis L; Hankins GR; Avallone FA; Livezey JR; Connelly R; Mostofi FK; McLeod DG; Moul JW; Chandrasekharappa SC; Srivastava S
Int J Cancer; 1999 Jun; 84(3):331-5. PubMed ID: 10371356
[TBL] [Abstract][Full Text] [Related]
2. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.
Konishi N; Nakamura M; Kishi M; Ishida E; Shimada K; Matsuyoshi S; Nagai H; Emi M
Cancer Sci; 2003 Sep; 94(9):764-8. PubMed ID: 12967473
[TBL] [Abstract][Full Text] [Related]
3. Characterization of frequently deleted 6q locus in prostate cancer.
Sun M; Srikantan V; Ma L; Li J; Zhang W; Petrovics G; Makarem M; Strovel JW; Horrigan SG; Augustus M; Sesterhenn IA; Moul JW; Chandrasekharappa S; Zou Z; Srivastava S
DNA Cell Biol; 2006 Nov; 25(11):597-607. PubMed ID: 17132090
[TBL] [Abstract][Full Text] [Related]
4. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of proximal 6q deletions in prostate cancer.
Cooney KA; Wetzel JC; Consolino CM; Wojno KJ
Cancer Res; 1996 Sep; 56(18):4150-3. PubMed ID: 8797584
[TBL] [Abstract][Full Text] [Related]
6. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Muto MG; Colitti CV; Bell DA; Welch WR; Berkowitz RS; Mok SC
Hum Pathol; 2000 Mar; 31(3):367-73. PubMed ID: 10746681
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
9. Allelic loss of chromosome 6q in gastric carcinoma.
Li BC; Chan WY; Li CY; Chow C; Ng EK; Chung SC
Diagn Mol Pathol; 2003 Dec; 12(4):193-200. PubMed ID: 14639105
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on chromosome arms 3p and 6q in microdissected adenocarcinomas of the uterine cervix and adenocarcinoma in situ.
Acevedo CM; Henríquez M; Emmert-Buck MR; Chuaqui RF
Cancer; 2002 Feb; 94(3):793-802. PubMed ID: 11857315
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 6q is frequent and concurrent with 3p loss in sporadic and familial capillary hemangioblastomas.
Lemeta S; Pylkkänen L; Sainio M; Niemelä M; Saarikoski S; Husgafvel-Pursiainen K; Böhling T
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1072-9. PubMed ID: 15535134
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of heterozygosity at 6q in pheochromocytoma.
Lemeta S; Salmenkivi K; Pylkkänen L; Sainio M; Saarikoski ST; Arola J; Heikkilä P; Haglund C; Husgafvel-Pursiainen K; Böhling T
Hum Pathol; 2006 Jun; 37(6):749-54. PubMed ID: 16733217
[TBL] [Abstract][Full Text] [Related]
14. Loss of two new loci on chromosome 8 (8p23 and 8q12-13) in human prostate cancer.
Perinchery G; Bukurov N; Nakajima K; Chang J; Hooda M; Oh BR; Dahiya R
Int J Oncol; 1999 Mar; 14(3):495-500. PubMed ID: 10024682
[TBL] [Abstract][Full Text] [Related]
15. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
[TBL] [Abstract][Full Text] [Related]
16. Putative tumor suppressor loci at 6q22 and 6q23-q24 are involved in the malignant progression of sporadic endocrine pancreatic tumors.
Barghorn A; Speel EJ; Farspour B; Saremaslani P; Schmid S; Perren A; Roth J; Heitz PU; Komminoth P
Am J Pathol; 2001 Jun; 158(6):1903-11. PubMed ID: 11395364
[TBL] [Abstract][Full Text] [Related]
17. Genetic pattern of prostate cancer progression.
Saric T; Brkanac Z; Troyer DA; Padalecki SS; Sarosdy M; Williams K; Abadesco L; Leach RJ; O'Connell P
Int J Cancer; 1999 Apr; 81(2):219-24. PubMed ID: 10188722
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
[TBL] [Abstract][Full Text] [Related]
20. [Inheritance instability of chromosome 6q in patients with gastric cancer].
Chen P; Chu YL; Song TS; Lei L; Wang JS; Wang K; Ni L; Niu YY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):852-5. PubMed ID: 17243293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
